Polychlorinated biphenyls (PCBs) are persistent environmental pollutants that are still causing potentially harmful effects to humans and wildlife. While the adverse health effects of PCBs have been extensively studied for decades, little is known about the effects specifically caused by the less potent, yet abundant non-dioxin-like congeners (NDL-PCBs). Here a non-targeted metabolic profiling of rat offspring exposed in utero and lactationally to total doses of 0, 300 or 1000 mg/kg body weight of ultrapure PCB 180 is reported. Serum samples from 5 male, and 5 female offspring from each group taken 12 weeks after birth were analyzed using UHPLCqTOF-MS system, and subsequent metabolite alterations were studied. Statistical analysis revealed gender and dose-dependent alterations in serum metabolite levels at doses that did not adversely influence maternal or offspring body weight development. Male rats exhibited a higher number of altered metabolites, as well as stronger dose-dependency. A total of 51 metabolites were identified based on spectral matching. Most notably, 20 of these were glycerophospholipids, mainly lysophosphocholines with systematically decreased concentrations especially in the high-dose males. Other major metabolite groups include amino acids, their derivatives and carnitines. Our findings are consistent with the earlier reported liver effects, as well as neurodevelopmental and neurobehavioral effects of PCB 180. They also emphasize the potential value of metabolomics in characterizing toxic effects and in identifying sensitive biomarkers with potential future use in health risk assessment.
Introduction
Decades after the end of their use and production, polychlorinated biphenyls (PCBs) persist in significant concentrations all over the biosphere (WHO, 2000; Öberg et al., 2002; Ritter et al., 2011) . Lipophilic PCBs accumulate in adipose tissues of animals, where they biomagnify in the food chain causing continuous internal human exposure particularly from consumption of fatty fish. PCBs can be classified according to their structure as either dioxin-like (DL) or non-dioxin-like (NDL) (EFSA, 2005a) . In the past the general focus on PCB risk assessments has been on the effects of DL-PCB congeners, due to their relatively higher toxicological potencies compared to NDL-PCBs, which however constitute for much higher proportions in environmental PCB mixtures. More recently, several agencies have addressed the potential health risk associated with exposure to NDL-PCBs in particular. In 2005, the Scientific Panel on Contaminants in the Food Chain of the European Food Safety Authority (EFSA) concluded that the safety margin between exposure and suspected effects seemed to be small, although available data was insufficient to support the establishment of health-based guidance values for NDL-PCBs (EFSA, 2005a) . In 2016 the Joint FAO/ WHO Expert Committee on Food Additives (JECFA) concluded that separate exposure to each of the most common six NDL-PCB congeners via food is not likely to cause health effects, however that available database is still insufficient for setting health-based limit values (JECFA, 2016) . In particular, the database was judged insufficient for in utero and lactational exposure scenarios.
Established effects of NDL-PCBs include effects on liver, thyroid function, behavior, central nervous system, endocrine system, reproduction and development and immunology (EFSA, 2005a; Rice, 2005; Viluksela et al., 2014) . Most of these effects are also characteristic to the toxicity of DL-congeners. Therefore, in both the current and previous health risk assessments it has been a common difficulty to definitively separate the effects caused specifically by NDL-PCBs, from those caused by DL-PCBs, as many of the studies have been conducted with NDL-PCB congeners of insufficient purity, and/or lacking information on the purification (EFSA, 2005a,b; JECFA/WHO, 2016) .
Metabolomics is the quantitative measurement of time-related multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification (Nicholson et al., 1999) . It has become a novel technique in toxicological research for collecting mechanistic information on toxic insults and their underlying mechanisms. More specifically, toxicometabolomics is utilized for identification of pathways of toxicity and clarification of signatures of toxicity that reflect the patterns of endogenous metabolite alterations predictive for hazard manifestation (Bouhifd et al., 2013) . Metabolomics can also be used for discovering biomarkers of toxicity. Only a few studies have so far utilized metabolomics for clarifying toxic effects of PCBs and none of them addressed the effects of perinatal exposure in the offspring. Three rodent studies used the commercial PCB mixture Aroclor 1254 (containing both DL-and NDL-PCB) either alone (Lu et al., 2010; O'Kane et al., 2013) or in combination with diethylhexyl phthalate (Zhang et al., 2012) . These studies reported several treatment-related metabolic changes but were not able to differentiate between DL and NDL congeners in terms of their relative contributions to the observations.
The aim of the current study was to identify metabolic alterations and affected metabolic pathways in rat offspring after in utero and lactational exposure to highly purified (without DL impurities) NDL-PCB 180 at dose levels that do not cause overt maternal or fetal toxicity. PCB 180 was chosen as the test compound as it is among the most abundant of the 209 possible congeners in the environment and biota, yet poorly characterized in terms of its toxicological effects . The focus of our study was on analyzing long-lasting consequences on the metabolome following exposure during the most sensitive period of life.
Materials and methods

Chemicals
PCB 180 (2,2′,3′,4,4′,5,5′-heptachlorobiphenyl; CAS 35065-29-3) was purchased from Chiron, Trondheim, Norway and analyzed for purity and for dioxin-like (DL) impurities. In brief, 20 mg PCB 180 was dissolved in n-hexane and applied on an activated carbon column, flushed with n-hexane and then back-flushed with toluene to recover DL contaminants (Danielsson et al., 2008) . The toluene fraction was analyzed using a gas chromatograph interfaced with a high-resolution mass spectrometer tuned for identification of DL-PCBs and PCDD/Fs. The purity of PCB 180 as stated by the supplier was 98.9% and the analyzed level of dioxin-like impurities was 2.7 ng WHO-TEQ/g PCB 180. The PCB was dissolved in purity-controlled corn oil (Sigma Aldrich, Munich, Germany; batch No. 065 K0077; dioxin-like impurities 0.2 pg WHO-TEQ/g) which served also as control.
Formic acid (HCOOH), and ammonium formate were purchased from Sigma (Sigma-Aldrich, St. Louis, MO). Acetonitrile was purchased from VWR International (Darmstadt, Germany) and Riedel-de Haën (Seelze, Germany), respectively. All mobile phase constituents were of LC-MS or LC-MS Ultra grade and other solvents and chemicals were of HPLC grade or higher. Water was purified using a Milli-Q Gradient system (Millipore, Milford, MA).
Animal study design
Female and male Sprague Dawley rats were obtained from Harlan Netherlands (Zeist, The Netherlands) and housed in single stainlesssteel cages (floor size 1380 cm 2 ) in a conventional laboratory animal unit of the National Institute for Health and Welfare (THL, Kuopio, Finland) . The unit is subjected regularly to health surveys consisting of serological and bacteriological screening as suggested by FELASA (1996) . Cages were supplied with a bedding of aspen chips (Tapvei Co., Kaavi, Finland). The room was artificially illuminated from 7 am to 7 pm, and air-conditioned to provide about 8 air changes per hour. The ambient temperature was 21 ± 2°C, and relative humidity was maintained at 50 ± 20%. Standard laboratory rodent diet (R36, Lactamin, Sweden) and water were available ad libitum. For mating, one female was transferred to the cage of one male. The morning of the day on which females were sperm-positive was taken as gestational day 0 (GD 0). Thereafter, females were housed in single cages.
The in utero and lactational exposure study design is not included in official test guidelines, but this study type is commonly used for studying effects of endocrine disrupting chemicals during critical periods of organogenesis in rats (Ostby and Gray Jr, 2004; US, 2005) . Pregnant females were randomized by body weight into one of six dose groups (7 per group), which were exposed to PCB 180 dissolved in corn oil daily on GDs 7-10 by oral gavage. Total dose levels of PCB 180 were 0, 10, 30, 100, 300, or 1000 mg/kg body weight and the dosing volume was 4 ml/kg body weight. Controls received only the vehicle. To allow uniform postnatal exposure the litter size was adjusted to 8, (4 males and 4 females), if possible, on postnatal day (PND) 1. Pup body weights were measured on PND 1, PND 4, and, then, once a week, starting on PND 7. After weaning on PND 28, littermates of the same sex were housed together in one cage. One offspring of each litter and sex was anesthetized with CO 2 /O 2 (70/30%) on PNDs 7, 35 and 84. Blood samples were drawn from the left ventricle using Venoject needles (Terumo) and Vacuette serum blood collection tubes, and the rats were killed by exsanguination. Serum was separated, divided into aliquots, frozen in liquid nitrogen and stored at −70°C for further analysis. A full necropsy including organ weights and tissue sampling for further biochemical, molecular biology and adipose tissue PCB 180 analyses was carried out and will be reported elsewhere. In addition, one offspring from each litter and sex were subjected to auditory and neurobehavioral testing (Lilienthal et al., 2011 (Lilienthal et al., , 2013 .
For the non-targeted metabolite profiling analysis, serum from 5 male and 5 female offspring given PCB 180 a total dose of 0, 300 or 1000 mg/kg bw and sampled on PND 84 were selected (30 animals in total). Male and female study groups are hereon referred by abbreviations M0, M300, M1000, F0, F300 and F1000.
All animal work was conducted in strict accordance with national and international guidelines. The study protocol was approved by the National Animal Experiment Board of Finland (license No. ESLH-2006-07965/Ym23).
Non-targeted metabolite profiling
Non-targeted metabolite profiling analysis was carried out at the LC-MS metabolomics center (Biocenter Kuopio, University of Eastern Finland). The serum samples were blinded, randomized and thawed on ice. Then, 100 μl of serum was mixed with 400 μl of ice-cold acetonitrile, Vortex mixed, incubated on ice for 15 min, and centrifuged at 16000 ×g for 10 min. The supernatant was filtered using 0.2 μm PTFE filters (PALL Corporation). The pooled sample was prepared for quality control sample, which was injected in the beginning of the analysis and after every 12 samples.
The non-targeted metabolite profiling was carried out using a UHPLC-qTOF-MS system (1290 UHPLC, Jetstream ESI source, 6540 UHD qTOF-MS, Agilent Technologies, Waldbronn, Karlsruhe, Germany). All samples were analyzed using two different chromatographic techniques; i.e., reversed phase (RP) and hydrophilic interaction chromatography (HILIC). RP is the most commonly used chromatographic mode due to its ability to separate a multiplicity of different metabolites. HILIC provides a complementary separation mode especially for polar metabolites with limited retention in RP. The combination of RP and HILIC offers wide metabolome coverage and optimal semi-quantitative analysis for most metabolites. In addition, data were acquired in both electrospray ionization (ESI) polarities; i.e., positive (ESI+) and negative (ESI-). The sample tray was at 4°C during these A. Pikkarainen, et al. Toxicology and Applied Pharmacology 370 (2019) 56-64 analyses.
For data acquisition, a mass range from m/z 50 to 1600 was used. For data dependent MS/MS analyses three different collision energies were 10, 20, and 40 V in subsequent runs. The TOF was calibrated daily and subsequently operated at high accuracy (< 2 ppm). Continuous mass axis calibration was performed throughout the analytical runs.
Details on the instrumentation has been previously described (Pekkinen et al., 2013) , and they are presented in Appendix A.
Molecular feature separation and quality control
A two-pass feature extraction process was used to find molecular features from the data. The data was first deconvoluted into individual chemical peaks using Agilent Technologies MassHunter Profinder (version B.06.00) software, using Batch Molecular Feature Extraction algorithm. The resulted molecular feature files were then imported into Agilent Technologies Mass Profiler Professional (MPP, version 13.1.1) software, in order to align, normalize, visualize and filter the features further. During this process, the data was filtered to create consensus feature lists based on a relative frequency threshold, corresponding to the number of features that were found in a defined percentage of at least one or more study groups i.e., male and female control groups M0 and F0, and the groups with the two exposure levels M300, F300 (300 mg/kg bw) and M1000, F1000 (1000 mg/kg bw). The created consensus feature list was then imported back to Profinder software, where each of the individual molecular features were manually analyzed to inspect the consistency of peak integration. The second pass employed the consensus feature list previously made with MPP and Profinder's Batch Targeted Molecular Feature Extraction workflow. The consistency of peak integration was inspected, and a missing feature recovery was performed across all samples. Additionally, weak chemical signals with excessive noise were eliminated from the data. The data was then imported further to subsequent statistical analyses.
Data filtering, statistical analysis, and visualization
All statistical analysis were done separately to RP and HILIC data sets. Statistical evaluation of the data used univariate and multivariate analyses with the Mass Profiler Professional software (MPP, version 12.6.1, Agilent Technologies). The data was binned, aligned, log2-transformed, and Z-transform baselined. Relative frequency threshold values of 100% were used for all experiments. Quality of the data was then observed by performing an unsupervised principle component analysis (PCA) with mean centering and scaling to visualize the clustering of the groups and their possible outliers. This was done separately to ESI+ and ESI-modes but including both gender groups and quality control (QC) samples i.e., mixtures of all of the male and female samples. PCA was then conducted for both genders separately without QC samples. One-way ANOVA was used to find features with statistically significant alterations between treated groups and controls in each gender. A p-value below 0.05 was considered statistically significant. Unsupervised PCA was performed with mean centering and scaling to visualize the variance of the metabolic phenotypes from the conditions based on the discriminating features calculated by the ANOVA analysis.
Additionally, the data was explored by Volcano plots i.e., the fold change of molecular feature normalized intensity was plotted against the statistical significance of this change obtained from an unpaired ttests, to find statistically differential molecular features. The unpaired ttests were conducted in pairs with fold change cut off value of 2.0 and corrected p-value cut off value of 0.05. The studied pairs were treatment groups F0 vs. F300, F0 vs. F1000, M0 vs. M300, and M0 vs. M1000 for both ESI polarities in HILIC and RP data groups. Therefore, a total of eight data sets of molecular features were created for further identification of metabolites. For statistically significant molecular features found in the Volcano plots, Venn diagrams were used to compare the occurrence of the individual molecular features within sample group pairs of each gender.
Identification
Identification of the statistically differing molecular features was based on their accurate mass, isotope information i.e., ratios, abundances, and spacing, as well as product ion spectra (MS/MS) by spectral matching to the published metabolite databases; Human Metabolome Database (HMDB) and METLIN, as well as a reference spectral library collected with the equipment used in the current study.
Level of identification (LI) for each individual molecular feature was determined based on the standards proposed by Sumner et al. (2007) , using the following criteria: identified compound based on spectral similarity and retention time with a reference compound (LI 1), putatively annotated compounds identified by spectral similarity based on an existing database (LI 2), putatively characterized compound classes e.g. based upon characteristic physicochemical properties of a chemical class of compounds, or by spectral similarity to known compounds of a chemical class (LI 3), unknown, but comparable with accurate mass, and spectral information (LI 4), and unknown (LI 5).
The terminology considering the chemical entities at different stages of metabolomics workflow has been described by Sana et al. (2013) . "Feature" describes in this case a chemical entity, which has been found using an untargeted peak finding algorithm, but has not been identified as a specific molecule. The term "metabolite" is used, when there is enough evidence (criteria for LI 1 and LI 2) to confirm a feature's identity. Here, the term metabolite is also used for the LI 3 identified features representing a likely candidate based on accurate mass and spectral similarity characteristic of a class of compounds.
Results
Body weight development and general observations
Exposure to PCB 180 induced slight and transient reduction in maternal body weight at the higher dose level (1000 mg/kg bw) from GD 11 to the end of pregnancy. Non-significantly decreased body weights were transiently observed in pups at the same dose level in the first postnatal week and thereafter the body weight was normalized. There were no treatment related differences in body weights on PNDs 35 or 84.
Metabolite profiling
In utero and lactational PCB 180 exposure resulted in gender-and dose-dependent alterations in the metabolome of rat offspring. Differences in the PCA score plot clustering can be seen in the Appendix B. PCA score plots indicate separate clusters if metabolic states among treatment groups are different. The initially conducted PCAs including the whole data showed separation of genders (Fig. B.1) . QC samples were tightly clustered, indicating good quality of data. Different dose levels did not show clear clustering, when PCA was done to both genders separately (data not shown). However, clustering was apparent in the PCAs including only the statistically different features separated by ANOVA (Figs. B.2 and B. 3).
Molecular features showing statistically significant and more than two-fold differences from controls as illustrated by the Volcano plots are presented in Figs. 1 and 2 . In a Volcano plot, the fold change of molecular feature normalized intensity is plotted against the statistical difference of this change obtained with an unpaired t-test. Data points above the horizontal, and lateral to the vertical green lines represent significantly differing molecular features. As can be seen in Fig. 1 , the amount of alterations was dose-dependently increased and the alterations in male rats exposed to 1000 mg/kg bw were largely on the side of decreasing concentration. Females showed a similar change at 300 mg/ kg bw.
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Identification of metabolites
All detected metabolites with the complete molecular feature lists are shown in Appendix C. and the summary of identified metabolites in Table 1 . We were able to nominate identities for 51 statistically significant metabolites between different treatment groups. In addition to the annotated metabolites, 131 molecular features are listed in Appendix C, for which corresponding MS-spectrums are available, but could not be matched to specific metabolites. The molecular features for which the product ion spectra could not be found, or which had lacking, or weak spectral information were excluded from identification.
A majority (a total of 20) of the annotated features were identified as glycerophospholipids, mostly either lysophosphatidylcholines (LysoPC) or lysophosphatidylethanolamines (LysoPE). The levels of 14 out of the 20 identified glycerophospholipids were decreased in males at 1000 mg/kg bw. In females, 5 glycerophospholipids were identified and 4 of them were decreased at 300 mg/kg bw and one at 1000 mg/kg bw.
Dose-dependency
In addition to the qualitative effects of different dose levels, quantitative dose-response information is available for those molecular features, which had altered levels at both doses within the same LC-MS set up (shown in the overlapping areas of each Venn diagram). For each significantly altered molecular feature, fold change and direction of regulation is listed in molecular feature lists (Appendix D). Due to nature of the data, fold change could not be calculated for some of the features. Furthermore, two of the features showed opposite responses at different doses.
A total of 84 features for males, and 11 for females showed dosedependent alterations (either increase or decrease), although for some of them the dose-responses were non-monotonic. In males, 70 features (83%) showed monotonic dose-responses, i.e. the fold change increased with increasing dose. In females, this was the case for 7 features (64%). Complete lists of statistically significantly altered molecular features, and separately features with applicable dose-dependency data are presented in Appendix D.
Only three of the identified metabolites were altered in both dose levels. The level of gulonic acid was increased in males by 2.5 and 5.4-fold at 300 and 1000 mg/kg bw, respectively, and the level of LysoPC(18:2) decreased by 2.1 and 2.5-fold, respectively. No dose-related alterations of identified metabolites were observed in females. With regard to similarities between males and females the level of LysoPE(16:0) was decreased in males at 1000 mg/kg bw and in females at 300 mg/kg bw, but increased in males at 300 mg/kg bw. Also the level of LysoPC(16:0) was decreased in males at 1000 mg/kg bw and in females at 300 mg/kg bw.
Discussion
The present study shows that in utero and lactational exposure to PCB 180 at dose levels that did not adversely influence maternal or offspring body weight development or cause severe general toxicity, resulted in specific gender and dose-dependent alterations in the metabolome of rat offspring. Dose-dependency was most apparent in terms of higher number of altered molecular features at the higher dose level in male rats. For those features which were altered in both dose levels, higher dose resulted in higher fold change of alteration more commonly in males, and to a lesser extent in females. The effects on the metabolome were observed at the age of 12 weeks, when body burden of PCB . The number of alterations increased dose-dependently in males in both RP and HILIC datasets. However, in females a dose-dependent increase was observed only in the HILIC ESI-mode (Fig. 4B ), but a decrease in the RP ESI-mode (Fig. 4D) . The clearly largest effects were observed in males at 1000 mg/kg bw. Female rats experienced overall fewer significant metabolome alterations, but had more alterations at 300 mg/kg bw than males in both HILIC and RP datasets in ESI-mode. Interestingly, most of the altered metabolites were different at 300 and 1000 mg/kg bw in both genders. A. Pikkarainen, et al. Toxicology and Applied Pharmacology 370 (2019) 56-64 (continued on next page) A. Pikkarainen, et al. Toxicology and Applied Pharmacology 370 (2019) 56-64 180 had already markedly decreased due to elimination and growth (Öberg et al., 2002) . The observed alterations were therefore likely of developmental origin. The number of significantly and more than two-fold altered metabolite levels were more frequent in males than in females. The higher number of treatment-related alterations in males is consistent with the more pronounced toxicological outcome of male rats (both in terms of number of effects and their sensitivity) in a 28-day toxicity study with PCB 180 . These included histopathological effects and induction of xenobiotic metabolism in liver. Because NDL-PCB toxicity involves activation of the constitutive active (androstane) receptor (CAR) (Kretschmer and Baldwin, 2005) , a possible explanation for the gender difference could be the higher amount of CAR in the liver of male rats compared with females and consequently, more pronounced induction of cytochrome P450 (CYP) 2B1 and CYP3A1, which are involved in the metabolism of numerous endogenous molecules, together with other CAR-mediated responses (Yoshinari et al., 2001; Roos et al., 2011) . Additionally, CAR has been shown to inhibit estrogen receptor mediated signalling pathway and repress transcriptional activation of estrogen receptors (Min et al., 2002; Timsit and Negishi, 2007) .
A majority of the altered metabolite concentrations in the present study were decreased levels of glycerophospholipids, mainly LysoPCs and LysoPEs, which were decreased especially in males at 1000 mg/kg bw. Glycerophospholipids are membrane components involved in transport of triacylglycerols and cholesterol that have been shown to be affected by PCBs and other persistent organic pollutants (POPs) (Carrizo et al., 2017) . In accordance with our results, O' Kane et al. (2013) reported decreased LysoPC (16:0) in plasma of Aroclor 1254-treated rats and Zhang et al. (2012) reported gender-specific changes in phosphatidylcholine (PC) and LysoPC concentrations in serum of mice after repeated exposure to the mixture of diethylhexyl phthalate (DEHP) and Aroclor 1254.
Considering the well-known hepatic effects of PCBs and sensitivity of males to these effects (Knerr and Schrenk, 2006; Roos et al., 2011; Viluksela et al., 2014) it is important to note that decreased serum levels of LysoPCs have been shown to reflect rapid membrane phosphatidylcholine turnover and to indicate early stage of liver injury. Decreased serum LysoPC proved to be an effective biomarker for early detection of carbon tetrachloride induced liver injury in rats prior to appearance of the characteristic histopathological alterations (Chang et al., 2017) . In targeted metabolomic profiling serum LysoPCs were also decreased in children and adolescent hospitalized due to paracetamol overdose (Bhattacharyya et al., 2016) . In the present study decreased serum LysoPCs can be considered to represent an early stage of hepatic alteration. In accordance with these findings metabolomic analysis of human serum samples indicated that exposure to PCBs and other chlorinated POPs at the higher end within the generally low European background exposure levels were associated with altered serum concentrations of glycerophospholipids (Carrizo et al., 2017; Salihovic et al., 2016) . Interestingly, exposure profiles characteristic for different POP groups or chemicals were related to different, chemical specific metabolic fingerprints. Altered regulation of lipid metabolism subsequent to exposure to these compounds could potentially play a role in pathogenesis of metabolic diseases such as diabetes (Ruzzin et al., 2012) .
Gulonic (gluconic) acid was one of the few identified metabolites that showed a dose-dependent decrease in serum of male rats. Toxicological significance of this alteration is not known, but in earlier studies chronic exposure of rats to two structurally different chlorinated compounds, the food processing contaminant 3-MCPD (3-chloro-1,2-propanediol) (Liu et al., 2013) or the organophosphate insecticide dichlorvos (2,2-dichlorovinyl dimethyl phosphate, DDVP) resulted in increased urine levels of gulonic acid.
Many of the identified metabolites in the present study are involved in neurological processes, which is consistent with the well-known effects of PCB exposure on the development and functioning of the nervous system (Huisman et al., 1995; WHO, 2000) . Most notably, 5-fold elevated kynurenine levels were found in male rats exposed to 300 mg/ kg bw. Kynurenine has been linked to various diseases, including many neurological disorders, due to its involvement in tryptophan catabolism (Arnhard et al., 2018) . Of the identified metabolites, also phenylalanine (decreased), indoxyl sulfate (decreased), and acetyltryptophan (increased) are involved in tryptophan metabolism. Elevated levels of kynurenine have been recorded in serum of schizophrenia patients (Fukushima et al., 2014) . Additionally, in metabolomics studies on patients suffering from neurological disorders, such as Alzheimer's disease, Parkinson's disease, and schizophrenia, altered levels of histamine, glutamine, pyroglutamic acid, allantoin, phenylalanine and many carnitines and glycerophospholipids have been observed (Kumar and Bachhawat, 2011; Fonteh et al., 2007; Xuan et al., 2011; Zhao et al., 2018) . Furthermore, decreased glycerophospholipid levels have been reported in plasma of schizophrenia patients (He et al., 2012) and post mortem brain samples from the caudate nucleus (Yao et al., 2000) . The number of affected metabolites with possible links to neurological disorders was much larger in male as compared to female rats (Table 1) .
In accordance with the findings in patients with neurological disorders, a number of different neurodevelopmental and neurobehavioral alterations have been reported in the siblings of rats of the present study, which links the observed metabolomic alterations to these effects. Male offspring showed pronounced dose-related reduction in latencies to movement onset during catalepsy induced by haloperidol, a dopamine receptor antagonist and a classical neuroleptic drug . This finding indicates that the dopaminergic system is a target of PCB 180-exposure and suggests enhanced dopaminergic activity in striatum. Other findings in the siblings include increased threshold of the brainstem auditory evoked potential in female offspring (Lilienthal et al., 2011) and supernormal sexually dimorphic behavior as illustrated by increased preference of female offspring to drink solution sweetened with saccharin (Lilienthal et al., 2013) . In addition, impaired learning ability in the Y maze task (but not impaired motor coordination) was observed in both male and female offspring at the age of 3-4 months after in utero and lactational exposure to the total dose level of 36 mg/kg bw of ultrapure PCB 180 (Boix et al., 2011) . a Level of identification: LI 1 = identified compound based on spectral similarity and retention time with a reference compound; LI 2: putatively annotated compounds identified by spectral similarity based on an existing database; LI 3: putatively characterized compound classes e.g. based upon characteristic physicochemical properties of a chemical class of compounds, or by spectral similarity to known compounds of a chemical class.
Conclusions
In utero and lactational exposure to purified PCB 180 resulted in gender specific and dose-dependent metabolome alterations in adult rat offspring. Male rats exhibited overall stronger metabolome alterations both in terms of higher number of altered metabolites, and more clear dose dependency than females. A total of 51 metabolites could be identified, most of which are glycerophospholipids with decreased regulation in the high-dose males. The study identified possible associations between altered metabolome and early stage liver effects as well as neurodevelopmental and neurobehavioral effects of PCB 180. Our findings emphasize the value of metabolomics in characterizing toxic effects and in identifying sensitive biomarkers of exposure with potential future use in health risk assessment of NDL-PCBs, and other environmental pollutants.
